Nuria Palacios
Overview
Explore the profile of Nuria Palacios including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
181
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Asla Q, Sarda H, Segui N, Martinez de Pinillos G, Mazarico-Altisent I, Capel I, et al.
Endocrine
. 2024 Jan;
83(3):747-756.
PMID: 38214877
Objective: Biochemical suspicion of familial hypocalciuric hypercalcemia (FHH) might provide with a negative (FHH-negative) or positive (FHH-positive) genetic result. Understanding the differences between both groups may refine the identification of...
2.
Mellid S, Gil E, Leton R, Caleiras E, Honrado E, Richter S, et al.
Front Endocrinol (Lausanne)
. 2023 Feb;
13:1070074.
PMID: 36760809
Introduction: The percentage of patients diagnosed with pheochromocytoma and paraganglioma (altogether PPGL) carrying known germline mutations in one of the over fifteen susceptibility genes identified to date has dramatically increased...
3.
Capdevila J, Trigo J, Aller J, Luis Manzano J, Garcia Adrian S, Zafon Llopis C, et al.
Eur J Endocrinol
. 2017 Jul;
177(4):309-317.
PMID: 28687563
Background: Axitinib, an antiangiogenic multikinase inhibitor (MKI), was evaluated in the compassionate use programme (CUP) in Spain (October 2012-November 2014). Subjects And Methods: 47 patients with advanced radioactive iodine (RAI)-refractory...
4.
Campdera M, Palacios N, Aller J, Magallon R, Martin P, Saucedo G, et al.
Pituitary
. 2015 Nov;
19(2):158-66.
PMID: 26586560
Introduction: Temozolomide (TMZ) is an oral alkylating agent that has been used over the past 8 years to treat aggressive pituitary tumors resistant to conventional therapy. To date, only 25...
5.
Rostomyan L, Daly A, Petrossians P, Nachev E, Lila A, Lecoq A, et al.
Endocr Relat Cancer
. 2015 Jul;
22(5):745-57.
PMID: 26187128
Despite being a classical growth disorder, pituitary gigantism has not been studied previously in a standardized way. We performed a retrospective, multicenter, international study to characterize a large series of...
6.
Valderrabano P, Aller J, Garcia-Valdecasas L, Garcia-Uria J, Martin L, Palacios N, et al.
Endocrinol Nutr
. 2013 Dec;
61(4):176-83.
PMID: 24355549
Objective: Transsphenoidal surgery (TSS) is the treatment of choice for Cushing's disease (CD). However, the best treatment option when hypercortisolism persists or recurs remains unknown. The aim of this study...
7.
Aller J, Palacios N, Lucas T
Endocrinol Nutr
. 2012 Sep;
55(4):188-9.
PMID: 22975458
No abstract available.
8.
Sanchez-Munoz I, Sanchez-Franco F, Vallejo M, Fernandez A, Palacios N, Fernandez M, et al.
Brain Res
. 2010 Dec;
1375:28-40.
PMID: 21184749
Brain derived neurotrophic factor (BDNF) increases the levels of somatostatin (SS) and its mRNA. To test the hypothesis that the regulation of SS synthesis by BDNF occurs at the transcriptional...
9.
Rodriguez-Acebes S, Palacios N, Botella-Carretero J, Olea N, Crespo L, Peromingo R, et al.
BMC Med Genomics
. 2010 Dec;
3:61.
PMID: 21182758
Background: Obesity results from an imbalance between food intake and energy expenditure, which leads to an excess of adipose tissue. The excess of adipose tissue and adipocyte dysfunction associated with...
10.
Sanchez-Munoz I, Sanchez-Franco F, Vallejo M, Fernandez A, Palacios N, Fernandez M, et al.
J Neurosci Res
. 2009 Oct;
88(4):825-36.
PMID: 19859966
Ca(2+) influx through L-type voltage-gated Ca(2+) channels (L-VSCC) is required for K(+)-induced somatostatin (SS) mRNA. Increase in intracellular Ca(2+) concentration leads to the activation of cyclic AMP-responsive element binding protein...